Making the Right Decisions With Incomplete Evidence in Early-Phase Oncology Trials

By attending this session, you will learn how to:

• Understand how early-phase oncology teams make critical decisions with incomplete and evolving data
• Learn how statistical design and analysis planning support dose escalation and cohort expansion decisions
• Explore the role of early endpoints, biomarkers, and PK data in shaping in-study choices
• Gain insight into decision-making approaches for basket trials and multi-cohort study designs
• See how in-stream analytics and visualizations enable timely and informed interpretation of clinical data
• Learn practical strategies to align cross-functional teams and governance during study conduct

• Data interpretation in early oncology development
• Decision-making under uncertainty in dose escalation and cohort expansion
• Integrating safety, PK, biomarkers, and early efficacy signals
• Statistical and operational considerations in complex trial designs
• Tools and frameworks for real-time data interpretation
• Aligning stakeholders to support confident and timely decisions

This webinar is designed for professionals across:

• Clinical Development and Clinical Operations professionals
• Biostatistics and Data Science teams
• Regulatory Affairs and Strategy leaders
• Safety and Pharmacovigilance professionals
• Oncology-focused biotech and pharmaceutical sponsors
• Teams involved in early-phase trial design and execution

Will a recording be available?
Yes, this is an on-demand webinar and available to watch at your convenience.

Who is this webinar for?
This session is intended for biotech and pharmaceutical professionals involved in early-phase oncology development who want practical guidance on interpreting data and making informed decisions under uncertainty.